Cytox (AgeTech UK) NeuroTech
Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway.
Connections from
Funding Status:
N/A
Headquarters:
United Kingdom
Founded Date:
N/A
Employee Number:
N/A
Industry:
UK AgeTech 2020
Technology:
AgeTech Companies
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A